DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 94.50.
Share Price | ₹5,958.5 | Nov 07,2024 |
Market Cap | ₹158,198.2 Cr | |
Earnings-TTM | ₹1,674.0 Cr | TTM-Consolidated Results |
Price/Earnings | 94.50x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹158,198.2 Cr] as on Nov 07,2024
(/) Earnings [ ₹1,674.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 94.50x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 94.50 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 44.87x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 41.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2024 at 56.92x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 38.33x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
DIVIS LABORATORIES | 1,674.00 | 94.50 | 158,198.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.60 | 429,841.0 |
CIPLA LTD | 4,485.22 | 28.33 | 127,063.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 19.86 | 107,398.0 |
ZYDUS LIFESCIENCES LTD | 4,181.90 | 23.40 | 97,866.3 |
MANKIND PHARMA LTD | 2,124.86 | 51.41 | 109,234.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 59.34 | 106,928.0 |
LUPIN LTD | 2,287.78 | 42.09 | 96,282.2 |
AUROBINDO PHARMA LTD | 3,533.22 | 22.20 | 78,437.3 |
ABBOTT INDIA LTD | 1,284.66 | 46.80 | 60,116.9 |
ALKEM LABORATORIES LTD | 2,073.89 | 32.99 | 68,407.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.86x |
Max industry PE | 94.50x |
Median industry PE | 38.60x |
Average industry PE | 41.77x |
You may also like the below Video Courses